Radiology & Imaging

Exploring ferumoxytol: A new frontier in MRI contrast agents

Magnetic resonance imaging (MRI) is a cornerstone in the landscape of medical diagnostics, celebrated for its non-ionizing and non-invasive nature. With nearly 40% of MRI procedures requiring contrast agents for optimal sensitivity, ...

Alzheimer's disease & dementia

Unlocking how to use mRNA to target Alzheimer's disease

Scientists at The Florey have developed an mRNA technology approach to target the toxic protein tau, which builds up in patients with Alzheimer's disease and other dementias.

Parkinson's & Movement disorders

New tool detects signs of motor neuron disease before symptoms begin

Scientists from the University of Aberdeen in collaboration with the University of Edinburgh and international partners, have identified a new way to detect signs of motor neuron disease (MND) in brain tissue that can pick ...

page 1 from 477